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Study design and methods: A cross-sectional study. A quantitative questionnaire was distributed to a sample of mothers attending
the Pediatrics Clinic at King Khalid University Hospital, Riyadh, Saudi Arabia.
Results: A total of 756 mothers responded to our questionnaire. Of the 756 filled questionnaires, 389 (51.67%) were male children.
5.3% of the mothers lived in non-urban settings. CNLDO was reported in the children attending the clinic by 17.1% (129/756) of
their mothers. Average age (±SD) of infants when persistent tearing was noticed was 3.2 ± 2.7 months, while average age (±SD) of
resolution was 9.6 ± 3.7 months. Of the children with CNLDO, 37.2% (48/129) still have persistent tearing at the time of
distributing the questionnaire. Among the group with CNLDO, 17% (22/129) of their mothers have experienced an infection
during pregnancy (p = 0.022). Within the same group, 14.7% (19/129) of the affected children were reported by their mothers
to have other children with CNLDO which was statistically significant (p = <0.001).
Conclusion: CNLDO could have a genetic predisposition and maternal infection is a possible risk factor for developing CNLDO.
Surgical management awareness should be emphasized to relieve children from this relatively common and benign condition.
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The nasolacrimal duct starts to develop during the fifth
week of embryogenesis.1 Congenital nasolacrimal duct
obstruction (CNLDO) is due to incomplete canalization of
the valve of Hasner at the distal part opening in the vast
majority of cases.2 Around 90% of cases gain patency no
longer than a year.3 Several studies have been done to
estimate the incidence of CNLDO which yielded a varied
range of results between 1.2% and 30%; probably the most
widely accepted incidence to be 6%3–7.
Risk factors for congenital anomalies may include maternal
infections during pregnancy, exposure to radiation or
consuming medications, and some occupational hazards5;these are similarly implicated in CNLDO. Moreover, the role
of genetics has not been thoroughly investigated in CNLDO.
In the literature, few familial cases were reported and among
them being one set of twins with bilateral dacryocystocele.8
There is a need to understand both impact and potential risk
factors for CNLDO. We conducted our study to identify
potential risk factors for developing CNLDO.
Study design and methods
A cross-sectional study design was adopted. The study
was carried out in the Pediatrics Clinic at King Khalid
University Hospital, Riyadh, Saudi Arabia and adhered with
the declaration of Helsinki. Questionnaires were distributede:
al.com
Arabia.
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the period of July 10th through September 15th. Our sample
size (n = 865) has been reached by applying the rule:
Samplesize ¼ fZ2  P  ð1  PÞg=C2
where: Z = Z value (1.96 for 95% confidence level).
P = 10% (the predicted prevalence of persistent tearing).
C = confidence interval ± 2%.
Confidence interval was relatively low in order to increase
the power of the study.
A specially designed questionnaire divided into two sec-
tions was distributed. The first section of the questionnaire
targeted the mother and father of the child. It explored
age, occupation, place of living, and smoking. Antenatal risk
factors were taken into consideration by asking about mater-
nal infections, drugs taken during pregnancy, and exposure
to X-ray. The second division was concerned with the pres-
ence of persistent tearing (with or without runny nose), the
presence of yellowish discharge, the age of onset, and the
age at resolution. Treatment options that had been offered
were also explored, if any. A pilot study was conducted
where 20 forms of our questionnaire were pretested in similar
settings on similar basis to test the reliability and validity of
the questionnaire. These 20 questionnaires were not in-
cluded in the final results.
We used the software SPSS 18 to analyze our data. The P-
value for Chi square test was calculated in all risk factors
potentially associating with CNLDO.Results
A total of 756 (out of 865) questionnaires have been satis-
factory filled by a sample of mothers attending the pediatrics
clinic. Almost one third of the mothers reported their child to
have tearing (284/756; 37.6%); however, 155 cases had tear-
ing coinciding only with an attack of common cold or after
the first 6 months of age. One hundred and twenty-nine
(17.1%) cases were reported by mothers to have persistent
tearing which commenced within the first 6 months of age
in the absence of upper respiratory tract infection which is
characteristic of CNLDO. Associated yellowish discharge
from the eye was reported in 35.7% (46/129) of infants withTable 1. Sociodemographic factors of both groups with and without congenita
Character
Gender of the child Male
Female
Place of living Urban
Non-urban
Mother’s age 11–25
25–35
35–40
>40
Mother’s education High school and below
University degree and above
Occupation of the mother Housewife
Working
Occupation of the father In-doors
Out-door
Smoking status of the mother Yes
No
Smoking status of the father Yes
NoCNLDO. None of them had features of acute attack of dacry-
ocystitis. Unilateral CNLDO was reported in 57.4% (74/129)
of cases (the left eye was involved in 30 cases, right eye in
21 cases and mothers failed to recall which eye was in partic-
ularly affected in 23 eyes). Bilateral involvement was reported
in 42.6% (55/129) of cases. Table 1 describes certain sociode-
mographic factors of such respondents.
Average age of infants with CNLDO was 3.2 ± 2.7 months,
and the average age (±SD) of resolution was
9.6 ± 7.5 months. Almost one third of cases with CNLDO re-
ported by mothers (48/129; represents 37.2%) had not been
resolved at the time of the study (thirty children were still be-
low the age of one year). Only 58.9% (76/129) of mothers
tried hydrostatic massage to their infant’s lacrimal sac. Spon-
taneous resolution without massage was reported in 32 chil-
dren, while massage aided resolution in 48 children. Of note,
only one case of persistent tearing (1/129; <1%) underwent a
successful probing. No cases of silastic intubation have been
reported in this study.
Nineteen reportedly affected patients (14.7%) had a first-
degree relative with CNLDO (p = <0.001). Twenty-two
mothers giving birth to an affected child (17.1%) reported
an infection during pregnancy (p = 0.022). Other risk factors
have been sought. However, none of them were statistically
significant. These are reflected in Table 2.
Discussion
Our study showed 17.1% incidence of CNLDO which falls
within many-reported incidence of CNLDO ranging from
1.2% to 30% depending on various criteria used in diagnos-
ing persistent tearing.5,6,9,10 In our study, the mean age of in-
fants with persistent tearing was 3.2 months which correlates
to the nature of the congenital disease. The current study
showed 42.6% bilateral affection which is higher than what
was reported by Kashkouli et al. (36.6%)11, the Pediatric
Eye Disease Investigator Group (33%),12 and Lim et al.
(17%).13 It is worthy to mention our previous retrospective
study that showed even higher percentage (45.8%) of bilat-
eral affection as it is dealt with the same population 14.
CNLDO resolution without any surgical intervention was
reported in 62% (80/129) of our series, in which ducts be-
came patent spontaneously in 24.8% (32/129) and with thel nasolacrimal duct obstruction (CNLDO).
CNLDO p-Value
Yes (%) No (%)
67 (51.9) 321 (51.2) 0.877
62 (48.1) 306 (48.8)
121 (93.8) 599 (95.5) 0.399
8 (6.2) 28 (4.5)
42 (32.6) 183 (29.2) 0.411
63 (48.8) 299 (47.7)
15 (11.6) 109 (17.4)
9 (7) 36 (5.7)
56 (43.4) 293 (46.7) 0.491
73 (56.6) 334 (53.3)
90 (69.8) 475 (75.8) 0.154
39 (30.2) 152 (24.2)
97 (75.2) 485 (77.4) 0.639
32 (24.8) 144 (22.6)
0 0 N/A
129 627
36 (27.9) 169 (27) 0.825
93 (72.1) 458 (73)
Table 2. Possible risk factors for developing congenital nasolacrimal duct obstruction (CNLDO) and their significance.
Possible risk factors CNLDO p-Value
Yes (%) No (%)
Other children with CNLDO Yes 19 (14.7) 21(3.3%) <0.001
No 110 (85.3) 606 (96.7%)
Had infection in pregnancy Yes 23 (17.8) 67 (10.7) 0.022
No 106 (82.2) 560 (89.3)
Had X-ray while pregnant Yes 8 (6.2) 26 (4.1) 0.305
No 121 (93.8) 601 (95.9)
Had drugs in first trimester Yes 24 (18.6) 128 (20.4) 0.640
No 105 (81.4) 499 (79.6)
60 F.D. Aldahash et al.aid of massage in 37.2% (48/129). This highlights the benign
course of CNLDO. However, our data are notably less than
MacEwen and Young’s large series who found spontaneous
resolution in 96% of cases during first year of life.6 Other
studies have also reported higher incidences of spontaneous
resolution ranging between 80% and 95%.5,10,15,16 The dis-
crepancy between our data and others could be due to nat-
ure of our study design as we did not follow our patients and
thirty (23.3%) unresolved children were still under the age of
1 year at the time of study which leaves the question open
whether they are going to improve with time.
Despite reporting unresolved CNLDO in 18 children
above the age of 1 year when the study was conducted, fam-
ilies did not seek medical advice. This highlights the need for
educational program to increase the awareness of the nature
of the disease and encourage families to seek for surgical
intervention after the age of 1 year as CNLDO is unlikely to
resolve spontaneously or with the aid of massage beyond this
age 17.
Scarce reports have looked at the inheritance of CNLDO.
For instance; Yie suggested sporadic or multiagency mode of
inheritance while Barham et al. argued the inheritance of
CNLDO.8,18 The current study showed an association be-
tween CNLDO and family history documented by higher rate
among first-degree siblings (p = <0.001). This association
may support the presence of genetic basis of the disease.
However, sound conclusion cannot be made with this study
design. We also found that infection during pregnancy is a
statistically significant risk factor (p = 0.022). Various studies
have reported association between maternal infection and
congenital anomalies, with respect to viral infection.19,20 On
the other hand, gender and age of the mother when giving
birth to the affected child, X-ray exposure, drug intake during
first trimester, gender of the child, place of living, parent’s
education, occupation, smoking status were not significant.
This finding is consistent with the finding published by Noda
et al.3
In summary, CNLDO could have a genetic predisposition
and maternal infection may also predispose to CNLDO.
Awareness should be emphasized on when intervention takes
place in order to manage children with this relatively benign
disease.Conflict of interest
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